Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Rhombod Intercostal Sub-Serratus Plane Block vs External Oblique Intercostal Block for Open Nephrectomy

Official title: Ultrasound Guided Rhomboid Intercostal Sub-serratus Plane Block Versus External Oblique Intercostal Block in Open Nephrectomy: Randomized Controlled Study

Run by Cairo University · NCT07642193 · Data updated 2026-11-12

This study tests whether the rhomboid intercostal sub-serratus plane block helps patients need less pain relief sooner after open nephrectomy compared with the external oblique intercostal block.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment90 (estimated)
SponsorCairo University
Academic / other
Locations1 site (Cairo)
StatusRecruiting
StartedMay 2, 2026
Main results expectedDecember 30, 2026
Study endsDecember 30, 2026
Registry record updatedJune 11, 2026
Trial IDNCT07642193 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults undergoing open nephrectomy with ASA physical status II–III and BMI between 20 and 35 kg/m2.

Probably not a fit

Patients with BMI outside the 20–35 range, ASA IV, or contraindications to regional anesthesia/local anesthetics may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Patients undergoing open nephrectomy are randomized to receive either a rhomboid intercostal sub-serratus plane block or an external oblique intercostal block for perioperative analgesia, with intravenous morphine as rescue. The trial compares the time to first request for analgesia between the two blocks. The RISS approach targets nerves from T4 to T9 and has been used in thoracic and upper abdominal surgeries; this study evaluates its effectiveness in open nephrectomy. Safety and analgesic duration will be monitored as secondary considerations. The design focuses on practical perioperative pain outcomes and could inform best regional anesthesia practices for this surgery.

Why it matters

Potential benefit: If successful, patients may experience longer-lasting pain relief and reduced need for opioids after open nephrectomy.

How similar studies have gone: Prior use of RISS blocks in thoracic and upper abdominal surgeries supports potential benefits, but evidence in open nephrectomy is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Both sexes.
* American Society of Anesthesiologists (ASA) physical status II, III.
* Body mass index (BMI): \> 20 kg/ m2 and \< 35 kg/ m2.
* Patients undergoing open nephrectomy.

Exclusion Criteria:

* Patient refusal.
* BMI \<20 kg/m2 and \>35 kg/m2
* Known sensitivity or contraindication to drug used in the study (local anesthetics, opioids).
* History of psychiatric and cognitive disorders or chronic pain.
* Contraindication to regional anesthesia e.g pre- existing peripheral neuropathies.
* Severe respiratory or cardiac disorders.
* Advanced liver or kidney disease.
* Pregnancy.
* Physical status ASA IV.
* Coagulopathy with INR ≥ 1.6: hereditary (e.g. hemophilia, fibrinogen abnormalities \& deficiency of factor II) - acquired (e.g. impaired liver functions with prothrombin concentration less than 60 %, vitamin K deficiency \& therapeutic anticoagulants drugs).

Where it's running

  • Cairo University
    Cairo, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.